#CTSM: Innovation In Clinical Trials
On this month’s #CTSM (Clinical Trials Social Media) Tweetchat we are discussing innovation in clinical trials.
Clinical trials—research studies involving people—test new therapies for cancer. A cancer clinical trial is the environment in which new cancer therapies are proven for their effectiveness. All medicines and treatments we currently use in the healthcare industry were once tested in a clinical trial after years of development in research labs. If not for this research process, we may not have Gleevec (sometimes used to treat Leukemia), the HPV vaccine, Avastin for non-small cell lung cancer, or Xalkori for ROS1 and ALK mutations—some of the best cancer treatment drugs available today.
As science and medicine have progressed, so has clinical trial design. It has evolved beyond the best-known, “Gold Standard” type of trial—Randomized Controlled Trials—to incorporate innovations from precision medicine and patient-centeredness.
T1. The Classic: Randomized Controlled Trials
T1. a. Moving Beyond Randomized Clinical Trials: What Is Behind The Push For Innovation?
- Precision Medicine
T2. Innovation: Basket Trials #BasketTrials
T2. a. Example of a Basket Trial: NCI-MATCH #NCIMATCH
T3. Umbrella Trials: #UmbrellaTrial
T3. a. Example of an Umbrella Trial: LUNG-MAP #LUNGMap
T4. Innovation: Adaptive Trials #AdaptiveTrials
T4 a. Example of an Adaptive Trial: GBM Agile #GBMAgile
T5. Innovation: Patient Reported Outcomes
T5 a. PCORI
Please join us for this edition of the #CTSM chat, Wednesday, March 22nd, 2017 at 9 PM Eastern!
Get started and a Cure Forward Clinical Trial Navigator will help you access active clinical trial options.